scholarly article | Q13442814 |
P356 | DOI | 10.3109/14756366.2011.622272 |
P698 | PubMed publication ID | 21999665 |
P50 | author | Erik W Hartwick | Q85097514 |
P2093 | author name string | Norman P Curthoys | |
P2860 | cites work | Isolation, characterization and expression of a human brain mitochondrial glutaminase cDNA | Q22253340 |
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
Functional and Structural Characterization of Four Glutaminases from Escherichia coli and Bacillus subtilis † | Q27650545 | ||
The biology of cancer: metabolic reprogramming fuels cell growth and proliferation | Q29547301 | ||
THE METABOLISM OF TUMORS IN THE BODY | Q29616202 | ||
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
Otto Warburg's contributions to current concepts of cancer metabolism | Q29617601 | ||
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis | Q29617613 | ||
Complexity and species variation of the kidney-type glutaminase gene | Q31066478 | ||
Targeting mitochondrial glutaminase activity inhibits oncogenic transformation | Q34807996 | ||
Glutaminase: a hot spot for regulation of cancer cell metabolism? | Q37828397 | ||
Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) | Q39253539 | ||
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. | Q39636555 | ||
Ehrlich ascites tumor cells expressing anti-sense glutaminase mRNA lose their capacity to evade the mouse immune system | Q40828562 | ||
Regulation of glutaminase activity and glutamine metabolism | Q40926056 | ||
Properties of rat renal phosphate-dependent glutaminase coupled to Sepharose. Evidence that dimerization is essential for activation | Q41839361 | ||
Inhibition by glutamate of phosphate-dependent glutaminase of rat kidney | Q42104953 | ||
Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase | Q44578001 | ||
Phosphate-dependent glutaminase from rat kidney. Cause of increased activity in response to acidosis and identity with glutaminase from other tissues | Q53724073 | ||
P433 | issue | 6 | |
P304 | page(s) | 861-867 | |
P577 | publication date | 2011-10-15 | |
P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
P1476 | title | BPTES inhibition of hGA(124-551), a truncated form of human kidney-type glutaminase | |
P478 | volume | 27 |
Q54943565 | A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines. |
Q38817911 | Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer |
Q51138025 | Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators. |
Q36517216 | Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. |
Q36749597 | Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation. |
Q35738138 | Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase |
Q37619803 | Expression of glutamine metabolism-related proteins in thyroid cancer |
Q33834498 | From Krebs to clinic: glutamine metabolism to cancer therapy. |
Q42364281 | Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition |
Q37707215 | Glutaminase regulation in cancer cells: a druggable chain of events. |
Q37684619 | Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes |
Q38260557 | Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy |
Q33889353 | Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors |
Q89401928 | Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase |
Q27003967 | Rho GTPases and their roles in cancer metabolism |
Q33587667 | Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration |
Q41943060 | T Helper Cell Activation and Expansion Is Sensitive to Glutaminase Inhibition under Both Hypoxic and Normoxic Conditions |
Q38592248 | Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach |
Q92932487 | Targeting glutamine metabolism slows soft tissue sarcoma growth |
Q36868552 | Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders |
Q64237577 | The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy |
Q38139096 | Therapeutic strategies impacting cancer cell glutamine metabolism |
Q38828988 | Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways |
Search more.